GlassScriptPhysician profile
Kim W Johnston
NPI 1417994096
$1,804.08
in general payments reported to CMS, 2019-2025
20 companies · $727 in 2025
The $727 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.56 · 2020: $208 · 2021: $405 · 2022: $100 · 2023: $116 · 2024: $151 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $663 · Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $663.00 |
| Food and Beverage | $331.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $691.00 | 2025 | Tlif |
| Nuvasive, INC. | $289.43 | 2021 | |
| Boston Scientific Corporation | $186.57 | 2020-2024 | Coveredge 32, Wavewriter Alpha Prime 16 |
| Baxter Healthcare | $106.05 | 2021-2025 | Floseal |
| Medtronic USA, INC. | $102.70 | 2020 | |
| Lemaitre Vascular, INC. | $75.13 | 2022-2025 | Anastoclip Gc 8cm (Medium) |
| Djo, LLC | $73.47 | 2020-2024 | Cmf |
| Stryker Corporation | $59.76 | 2021-2024 | Spinejack |
| Nevro Corp. | $58.61 | 2019 | |
| Spineology INC. | $24.22 | 2020 | |
| Si-Bone, INC. | $23.77 | 2024 | |
| Innovation Technologies INC | $19.72 | 2024 | Irrisept |
| Elutia, INC. | $15.67 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.64 | 2023 | Andexxa |
| Spinal Elements, INC. | $14.14 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $13.81 | 2022 | |
| Zimmer Biomet Holdings, INC. | $13.69 | 2019 | |
| Irras USA, INC. | $13.11 | 2020 | |
| Cerapedics INC. | $8.59 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$123,061.44 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.